RNA therapeutics represents a cutting-edge frontier in the field of medical science, offering innovative solutions to tackle a myriad of diseases. At its core, RNA therapeutics harnesses the power of nucleic acids to modulate gene expression, paving the way for targeted treatments. This revolutionary approach holds promise in addressing genetic disorders, infectious diseases, and various types of cancers. The key player in RNA therapeutics is messenger RNA (mRNA), which acts as a messenger carrying genetic instructions to cells. mRNA therapeutics have gained prominence, particularly with the successful development of COVID-19 vaccines utilizing this technology. This success has opened new avenues for exploring mRNA-based treatments for other diseases.
Beyond mRNA, RNA interference (RNAi) is another pivotal aspect of RNA therapeutics. RNAi enables the selective silencing of specific genes, presenting opportunities to intervene in disease processes at the genetic level. This mechanism has shown promise in treating conditions ranging from neurodegenerative disorders to viral infections. As research in RNA therapeutics advances, the potential for personalized medicine becomes more evident. Tailoring treatments based on an individual's genetic makeup holds the key to more effective and targeted therapies. With ongoing breakthroughs, RNA therapeutics stands poised to reshape the landscape of medicine, offering hope for patients with unmet medical needs.
Therapeutics based on small interfering RNA (siRNA) have demonstrated tremendous potential for treating cancer. However, non-specific targeting, premature degradation, and intrinsic toxicity of the…
Participants can earn 1 CPD credit for each hour of attendance.
Oral and poster slots for original RNA Therapeutics work, reviewed by the scientific committee.
Meet nanotechnologists, researchers, scientists and engineers from around the world across three days.
In-person and virtual registrations include an electronic copy of the abstract book.
Plenary lectures from leading voices shaping RNA Therapeutics research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The RNA Therapeutics track is a dedicated stream within World Nano 2027 covering the latest research, innovation, and best practice in RNA Therapeutics. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Nanotechnology researchers, scientists and engineers, educators and students with an interest in RNA Therapeutics are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Yes. World Nano 2027 is a hybrid conference — attend the RNA Therapeutics track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.
